Dr. Christina Ha of Mayo Clinic Arizona presents this lecture for GI fellows to better understand Biosimilars and how to incorporate them into clinical practice. You will learn the evidence of efficacy and safety of biosimilars. This lecture also focuses on patient and provider communication patterns along with participation in shared decision making for optimal compliance and patient outcomes.
Additional Resources:
Clinical Pearl: Role of Therapeutic Drug Monitoring of Biologics in the Treatment of IBD
Published: 9/8/2022
Facebook Comments